Pharma IQ | 04/20/2010
Pharma IQ speaks with Earl Sullivan, Chief Executive Officer, Landela Pharmaceutical, about working with an overseas CMO to gain FDA inspection and approved status.
To continue reading this story Click Here
RECOMMENDED
The Trust Equation: Why Transparency Defines the Future Winners in Contract Manufacturing
2025-12-17
Upcoming Events
DigIT Pharma 2026 | AI Commercial, Medical & Patient Care
September 9 - 10, 2026
Berlin, Germany
Register Now |
View Agenda |
Learn More